Treating the U87 glioma cell line with EGFR-targeted diphtheria toxin (DT-EGF) induced cell death by autophagy, promoting the release of immunomodulatory factors like the high-mobility group box protein 1 (HMGB1), reducing the inflammatory response and inhibiting necrosis [125]. The gene discussed is EGFR; the disease is central nervous system cancer.